Riskpilot← Back to searchSign inGet full accessSANA UTVIKLING AS
ASActiveOrg 980360911Markens Gate 34, 4612 Kristiansand SOther human health activities n.e.c. · NACE 8699Est. 19980 employees
Revenue 2024
NOK 0
EBITDA margin
—
+23% vs 2023
Equity ratio
2.8%
Financial strength
Net profit 2024
NOK -31K
-101% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -63K | +23% |
| Net profit | NOK -31K | -101% |
| Total assets | NOK 4,6M | -5% |
| Equity | NOK 130K | -19% |
| Employees | 0 | — |
Legal name
SANA UTVIKLING AS
Org number
980360911
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
1. desember 1998
Share capital
NOK 237 077
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene eller styrets leder alene.
Company purpose
Selskapets formål er utvikling av mottaksdrift, etablering og deltakelse av nye forretningsområder, investeringer i andre selskaper og virksomheter samt det som naturlig står i forbindelse med dette.
Address
Markens Gate 34, 4612 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 146 | 0 | 0 | 0 | 0 |
| Staff expenses | −374 | −4 | −3 | −13 | −0 |
| EBITDA | −688 | −122 | −119 | −82 | −63 |
| Depreciation & amort. | −40 | −0 | −0 | −0 | −0 |
| EBIT | −728 | −122 | −119 | −82 | −63 |
| Net financials | −21 | −7 | −12 | −11 | 23 |
| Profit before tax | −749 | −129 | −130 | −93 | −40 |
| Tax | −0 | −0 | −0 | −2 767 | −9 |
| Net profit | −749 | −129 | −130 | 2 674 | −31 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 215 | 2 260 | 2 069 | 4 838 | 4 604 |
| Equity | −2 254 | −2 383 | −2 513 | 161 | 130 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 469 | 4 643 | 4 582 | 4 677 | 4 475 |
| Total debt | 4 469 | 4 643 | 4 582 | 4 677 | 4 475 |
EBITDA margin
-6312200.0%
This company
15.8%
Market median
-39950733% vs market
20202024
Equity ratio
2.8%
This company
38.2%
Market median
-93% vs market
20202024
Return on equity
-23.9%
This company
18.4%
Market median
-230% vs market
20202024
Net profit margin
-3102300.0%
This company
8.1%
Market median
-38300100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
34.51×
This company
0.62×
Market median
-5466% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AD Deputy Member | Deputy Member | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Stiftelsen Sana
SANA UTVIKLING AS Board members of SANA UTVIKLING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arve Danielsen | Deputy Member | 0 companies |
| Bjørn Halvorsen | Chairman | 0 companies |